A CD123-targeting antibody-drug conjugate, IMGN632, designed to eradicate AML while sparing normal bone marrow cells.
Saved in:
| Title: | A CD123-targeting antibody-drug conjugate, IMGN632, designed to eradicate AML while sparing normal bone marrow cells. |
|---|---|
| Authors: | Kovtun Y; Science, Technology, and Translation, ImmunoGen, Inc, Waltham MA., Jones GE; Science, Technology, and Translation, ImmunoGen, Inc, Waltham MA., Adams S; Science, Technology, and Translation, ImmunoGen, Inc, Waltham MA., Harvey L; Science, Technology, and Translation, ImmunoGen, Inc, Waltham MA., Audette CA; Science, Technology, and Translation, ImmunoGen, Inc, Waltham MA., Wilhelm A; Science, Technology, and Translation, ImmunoGen, Inc, Waltham MA., Bai C; Science, Technology, and Translation, ImmunoGen, Inc, Waltham MA., Rui L; Science, Technology, and Translation, ImmunoGen, Inc, Waltham MA., Laleau R; Science, Technology, and Translation, ImmunoGen, Inc, Waltham MA., Liu F; Science, Technology, and Translation, ImmunoGen, Inc, Waltham MA., Ab O; Science, Technology, and Translation, ImmunoGen, Inc, Waltham MA., Setiady Y; Science, Technology, and Translation, ImmunoGen, Inc, Waltham MA., Yoder NC; Science, Technology, and Translation, ImmunoGen, Inc, Waltham MA., Goldmacher VS; Science, Technology, and Translation, ImmunoGen, Inc, Waltham MA., Chari RVJ; Science, Technology, and Translation, ImmunoGen, Inc, Waltham MA., Pinkas J; Science, Technology, and Translation, ImmunoGen, Inc, Waltham MA., Chittenden T; Science, Technology, and Translation, ImmunoGen, Inc, Waltham MA. |
| Source: | Blood advances [Blood Adv] 2018 Apr 24; Vol. 2 (8), pp. 848-858. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
